Fetal therapies as standard prenatal care in Japan

With recent advances in fetal medicine, various attempts have been made to save fetuses facing perinatal death or devastating consequences despite optimal management after birth. The concept of the fetus as a patient has been established through the application of in utero treatments. This paper rev...

Full description

Bibliographic Details
Main Authors: Haruhiko Sago, Seiji Wada
Format: Article
Language:English
Published: Korean Society of Obstetrics and Gynecology 2020-03-01
Series:Obstetrics & Gynecology Science
Subjects:
Online Access:http://www.ogscience.org/upload/pdf/ogs-63-108.pdf
_version_ 1828472774187810816
author Haruhiko Sago
Seiji Wada
author_facet Haruhiko Sago
Seiji Wada
author_sort Haruhiko Sago
collection DOAJ
description With recent advances in fetal medicine, various attempts have been made to save fetuses facing perinatal death or devastating consequences despite optimal management after birth. The concept of the fetus as a patient has been established through the application of in utero treatments. This paper reviews fetal therapies in order to highlight the role of perinatal medicine as standard prenatal care. Fetal therapies consist of medical therapy, percutaneous ultrasound-guided surgery, fetoscopic surgery, and open fetal surgery. In the 1980s, with advances in ultrasound imaging, percutaneous ultrasound-guided surgeries such as vesicoamniotic shunting for lower urinary tract obstruction and thoracoamniotic shunting (TAS) for fetal hydrothorax (FHT) were started. In the 1990s, fetoscopic laser surgery (FLS) for twin-twin transfusion syndrome (TTTS) was introduced, and later, a fetoscopic approach for congenital diaphragmatic hernia was also established. The revival of open fetal surgery, introduced in the 1980s by pediatric surgeons, began in the 2010s after a successful clinical study for myelomeningocele. Although many fetal therapies are still considered experimental, some have proven effective, such as FLS for TTTS, TAS for primary FHT, and radiofrequency ablation (RFA) for twin reversed arterial perfusion (TRAP) sequence. These three fetal therapies have been approved for coverage by Japan National Health Insurance as a result of clinical studies performed in Japan. FLS for TTTS, TAS for primary FHT, and RFA for TRAP sequence have become standard prenatal care approaches in Japan. These three minimally invasive fetal therapies will help improve the perinatal outcomes of fetuses with these disorders.
first_indexed 2024-12-11T05:34:49Z
format Article
id doaj.art-d99e37d3e0804ac7b720861baeba8071
institution Directory Open Access Journal
issn 2287-8572
2287-8580
language English
last_indexed 2024-12-11T05:34:49Z
publishDate 2020-03-01
publisher Korean Society of Obstetrics and Gynecology
record_format Article
series Obstetrics & Gynecology Science
spelling doaj.art-d99e37d3e0804ac7b720861baeba80712022-12-22T01:19:19ZengKorean Society of Obstetrics and GynecologyObstetrics & Gynecology Science2287-85722287-85802020-03-0163210811610.5468/ogs.2020.63.2.108629Fetal therapies as standard prenatal care in JapanHaruhiko Sago0Seiji Wada1Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, .JapanCenter for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, .JapanWith recent advances in fetal medicine, various attempts have been made to save fetuses facing perinatal death or devastating consequences despite optimal management after birth. The concept of the fetus as a patient has been established through the application of in utero treatments. This paper reviews fetal therapies in order to highlight the role of perinatal medicine as standard prenatal care. Fetal therapies consist of medical therapy, percutaneous ultrasound-guided surgery, fetoscopic surgery, and open fetal surgery. In the 1980s, with advances in ultrasound imaging, percutaneous ultrasound-guided surgeries such as vesicoamniotic shunting for lower urinary tract obstruction and thoracoamniotic shunting (TAS) for fetal hydrothorax (FHT) were started. In the 1990s, fetoscopic laser surgery (FLS) for twin-twin transfusion syndrome (TTTS) was introduced, and later, a fetoscopic approach for congenital diaphragmatic hernia was also established. The revival of open fetal surgery, introduced in the 1980s by pediatric surgeons, began in the 2010s after a successful clinical study for myelomeningocele. Although many fetal therapies are still considered experimental, some have proven effective, such as FLS for TTTS, TAS for primary FHT, and radiofrequency ablation (RFA) for twin reversed arterial perfusion (TRAP) sequence. These three fetal therapies have been approved for coverage by Japan National Health Insurance as a result of clinical studies performed in Japan. FLS for TTTS, TAS for primary FHT, and RFA for TRAP sequence have become standard prenatal care approaches in Japan. These three minimally invasive fetal therapies will help improve the perinatal outcomes of fetuses with these disorders.http://www.ogscience.org/upload/pdf/ogs-63-108.pdffetoscopyfetal therapyfetofetal transfusionradiofrequency therapyultrasonogaphy
spellingShingle Haruhiko Sago
Seiji Wada
Fetal therapies as standard prenatal care in Japan
Obstetrics & Gynecology Science
fetoscopy
fetal therapy
fetofetal transfusion
radiofrequency therapy
ultrasonogaphy
title Fetal therapies as standard prenatal care in Japan
title_full Fetal therapies as standard prenatal care in Japan
title_fullStr Fetal therapies as standard prenatal care in Japan
title_full_unstemmed Fetal therapies as standard prenatal care in Japan
title_short Fetal therapies as standard prenatal care in Japan
title_sort fetal therapies as standard prenatal care in japan
topic fetoscopy
fetal therapy
fetofetal transfusion
radiofrequency therapy
ultrasonogaphy
url http://www.ogscience.org/upload/pdf/ogs-63-108.pdf
work_keys_str_mv AT haruhikosago fetaltherapiesasstandardprenatalcareinjapan
AT seijiwada fetaltherapiesasstandardprenatalcareinjapan